Literature DB >> 20864329

Surface plasmon resonance biosensor for parallelized detection of protein biomarkers in diluted blood plasma.

Marek Piliarik1, Markéta Bocková, Jiří Homola.   

Abstract

Surface plasmon resonance (SPR) biosensor for high-throughput screening of protein biomarkers in diluted blood plasma is reported. The biosensor combines a high-resolution SPR imaging sensor and a high-density protein array with low-fouling background. The SPR imaging sensor utilizes polarization contrast and advanced referencing and provides a total of 120 sensing areas (each 200 μm×150 μm). Antibodies are immobilized on the sensing areas via hybridization of antibody-oligonucleotide conjugates to thiolated complementary oligonucleotides microspotted on the sensor surface (DNA-directed immobilization). A low-fouling background is achieved by covalent immobilization of bovine serum albumin to carboxyl-terminated thiols filling the areas among the thiolated oligonucleotides and outside the sensing areas. The biosensor was evaluated for detection of protein biomarkers relevant to cancer diagnostics--human chorionic gonadotropin (hCG) and activated leukocyte cell adhesion molecule (ALCAM) both in buffer and in 10% blood plasma. Limits of detection as low as 45 ng/mL (ALCAM) and 100 ng/mL (hCG) were achieved in blood plasma samples.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20864329     DOI: 10.1016/j.bios.2010.08.063

Source DB:  PubMed          Journal:  Biosens Bioelectron        ISSN: 0956-5663            Impact factor:   10.618


  21 in total

1.  Real-time and Label-free Bio-sensing of Molecular Interactions by Surface Plasmon Resonance: A Laboratory Medicine Perspective.

Authors:  Erik Helmerhorst; David J Chandler; Matt Nussio; Cyril D Mamotte
Journal:  Clin Biochem Rev       Date:  2012-11

2.  Protein analytical assays for diagnosing, monitoring, and choosing treatment for cancer patients.

Authors:  Alicia D Powers; Sean P Palecek
Journal:  J Healthc Eng       Date:  2012-12       Impact factor: 2.682

3.  A multiplexed immunoaggregation biomarker assay using a two-stage micro resistive pulse sensor.

Authors:  Y Han; H Wu; F Liu; G Cheng; J Zhe
Journal:  Biomicrofluidics       Date:  2016-03-16       Impact factor: 2.800

4.  Evaluation of the Spectral Response of Functionalized Silk Inverse Opals as Colorimetric Immunosensors.

Authors:  Kelly A Burke; Mark A Brenckle; David L Kaplan; Fiorenzo G Omenetto
Journal:  ACS Appl Mater Interfaces       Date:  2016-06-20       Impact factor: 9.229

5.  Focal molography is a new method for the in situ analysis of molecular interactions in biological samples.

Authors:  Volker Gatterdam; Andreas Frutiger; Klaus-Peter Stengele; Dieter Heindl; Thomas Lübbers; Janos Vörös; Christof Fattinger
Journal:  Nat Nanotechnol       Date:  2017-09-25       Impact factor: 39.213

6.  Protein biomarker druggability profiling.

Authors:  Subramani Mani; Daniel Cannon; Robin Ohls; Tudor Oprea; Stephen Mathias; Karri Ballard; Oleg Ursu; Cristian Bologa
Journal:  J Biomed Inform       Date:  2017-01-25       Impact factor: 6.317

7.  A revised LRSPR sensor with sharp reflection spectrum.

Authors:  Yinquan Yuan; Yutang Dai
Journal:  Sensors (Basel)       Date:  2014-09-05       Impact factor: 3.576

Review 8.  Recent Advancements in Receptor Layer Engineering for Applications in SPR-Based Immunodiagnostics.

Authors:  Marcin Drozd; Sylwia Karoń; Elżbieta Malinowska
Journal:  Sensors (Basel)       Date:  2021-05-29       Impact factor: 3.576

9.  Near cut-off wavelength operation of resonant waveguide grating biosensors.

Authors:  Balint Kovacs; Fabio Aldo Kraft; Zsolt Szabo; Yousef Nazirizadeh; Martina Gerken; Robert Horvath
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

Review 10.  Early lung cancer diagnosis by biosensors.

Authors:  Yuqian Zhang; Dongliang Yang; Lixing Weng; Lianhui Wang
Journal:  Int J Mol Sci       Date:  2013-07-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.